Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
CK Life Sciences International (Holdings), Inc. ( (HK:0775) ) has provided an update.
CK Life Sciences International (Holdings) Inc. has issued a profit warning, indicating an expected loss of approximately HK$150 million for the first half of 2025, compared to a HK$1 million profit in the same period in 2024. This shift from profit to loss is primarily due to the company’s strategic decision to increase investments in research and development, while the overall operations remained stable. The final financial results are still being finalized and will be disclosed in the interim results announcement on 12 August 2025.
More about CK Life Sciences International (Holdings), Inc.
CK Life Sciences International (Holdings) Inc. operates in the biotechnology industry, focusing on research and development in life sciences. The company is engaged in producing pharmaceuticals, nutraceuticals, and agriculture-related products, with a market focus on advancing health and environmental sustainability.
Average Trading Volume: 9,385,691
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.61B
For an in-depth examination of 0775 stock, go to TipRanks’ Overview page.